This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Dermatologic Disorders, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Report of a Case

A 67-year old woman with follicular non-Hodgkin lymphoma received a standard 4-week course of rituximab. After receiving the third dose of rituximab, she started developing increasing pruritus and a generalized rash. Physical examination revealed scattered hemorrhagic vesicles on the back and flanks and pink macules on the trunk. There were prominent hemorrhagic vesicles and bullae on the upper arms and the palms (Figure 1); grouped hemorrhagic vesicles and bullae in the upper thighs and dorsum of the legs with some areas of necrosis; and punched out ulcerations on the back of the thighs. She developed short-lived oral ulcerations involving the palate, tongue, and floor of the mouth (Figure 2). Findings from laboratory investigations were unremarkable except for a mild increase in platelet count and C3, normal C4, and CH50 levels and an elevated erythrocyte sedimentation rate (84 mm/h). Findings from a direct fluorescent antibody preparation for . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION
Praveen Kandula, MD; Peter A. Kouides, MD